跳至主要内容
ProhibitedBinding ruleCNOfficial English translation已检查官方来源导入

抗组胺药,包括但不限于溴苯那敏及其 盐类、氯苯沙明、赛克利嗪及其盐类、 苯海拉明及其盐类、多西拉敏及其盐 类、羟嗪、曲吡那敏、西咪替丁等 — Antihistamines, including but not limited to Brompheniramine (INN) (CAS No. 86-22-6)and its salts, Chlorphenoxamine (INN) (CAS No. 77-38-3), Cyclizine (INN) (CAS No. 82-92-8) and its salts, Diphenhydramine (INN) (CAS No. 58-73-1) and its salts, Doxylamine (INN) (CAS No. 469-21-6) and its salts, Hydroxyzine (INN) (CAS No. 68-88-2), Tripelennamine (INN) (CAS No. 91-81-6), Cimetidine (INN) (CAS No. 51481-61-9)

Antihistamines, including but not limited to Brompheniramine (INN) (CAS No. 86-22-6)and its salts, Chlorphenoxamine (INN) (CAS No. 77-38-3), Cyclizine (INN) (CAS No. 82-92-8) and its salts, Diphenhydramine (INN) (CAS No. 58-73-1) and its salts, Doxylamine

The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.

监管决定及完整条件

状态
Prohibited
法律地位
Binding rule
监管摘要
The NMPA binding 2021 catalogue prohibits this raw material in cosmetic formulas in China.
条件与限制

Prohibited in cosmetic product formulas. Verify the cited Chinese source identity and any later NMPA amendment before use.

物质身份

官方来源名称
抗组胺药,包括但不限于溴苯那敏及其 盐类、氯苯沙明、赛克利嗪及其盐类、 苯海拉明及其盐类、多西拉敏及其盐 类、羟嗪、曲吡那敏、西咪替丁等 — Antihistamines, including but not limited to Brompheniramine (INN) (CAS No. 86-22-6)and its salts, Chlorphenoxamine (INN) (CAS No. 77-38-3), Cyclizine (INN) (CAS No. 82-92-8) and its salts, Diphenhydramine (INN) (CAS No. 58-73-1) and its salts, Doxylamine (INN) (CAS No. 469-21-6) and its salts, Hydroxyzine (INN) (CAS No. 68-88-2), Tripelennamine (INN) (CAS No. 91-81-6), Cimetidine (INN) (CAS No. 51481-61-9)
CAS
86-22-6; 77-38-3; 82-92-8; 58-73-1; 469-21-6; 68-88-2; 91-81-6; 51481-61-9
EC
Not supplied in this source row
身份映射
standalone:official_nmpa_record

该身份的跨市场概览

本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。

10 个市场数据集
CAS 469-21-6 的 PubChem 二维化学结构
CAS 469-21-6PubChem CID 3162

CAS 469-21-6 的已核实化学信息

Doxylamine

Doxylamine is a member of pyridines and a tertiary amine. It has a role as a sedative, a H1-receptor antagonist, a histamine antagonist, a cholinergic antagonist, an anti-allergic agent, an antiemetic and an antitussive. — ChEBI

IUPAC 名称
N,N-dimethyl-2-(1-phenyl-1-pyridin-2-ylethoxy)ethanamine
分子式
C17H22N2O
分子量
270.37 g/mol
精确质量
270.173213330 Da
单同位素质量
270.173213330 Da
XLogP3
2.5
拓扑极性表面积
25.4 Ų
分子复杂度
276.0
形式电荷
0
氢键供体
0
氢键受体
3
可旋转键
6
重原子
20
共价单元
1

向 PubChem 报告的名称和同义词

DossilaminaDoxylaminumDoxilminiodoxilamina2-Dimethylaminoethoxyphenylmethyl-2-picolineN,N-Dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)ethanaminePhenyl-2-pyridylmethyl-beta-N,N-dimethylaminoethyl ether2-(alpha-(2-(Dimethylamino)ethoxy)-alpha-methylbenzyl)pyridine
另有 16 个已报告名称
95QB77JKPLdimethyl({2-[1-phenyl-1-(pyridin-2-yl)ethoxy]ethyl})amineEthanamine, N,N-dimethyl-2-(1-phenyl-1-(2-pyridinyl)ethoxy)-CHEBI:51380Pyridine, 2-(alpha-(2-(dimethylamino)ethoxy)-alpha-methylbenzyl)-Ethanamine, N,N-dimethyl-2-[1-phenyl-1-(2-pyridinyl)ethoxy]-dimethyl((2-(1-phenyl-1-(pyridin-2-yl)ethoxy)ethyl))amine(+-)-DoxylamineRefChem:55070R06AA09207-414-2(+/-)-DoxylamineS-DoxylamineNCI C60684Doxylamine (INN)Doxylaminephenyl-d5
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
1
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
2
三维疏水基团
0
三维受体特征
2
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
1
三维构象异构体
10
有效三维可旋转键
6.0
机器可读的结构标识符
SMILES
CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C
InChI
InChI=1S/C17H22N2O/c1-17(20-14-13-19(2)3,15-9-5-4-6-10-15)16-11-7-8-12-18-16/h4-12H,13-14H2,1-3H3
InChIKey
HCFDWZZGGLSKEP-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 51481-61-9 的 PubChem 二维化学结构
CAS 51481-61-9PubChem CID 2756

CAS 51481-61-9 的已核实化学信息

Cimetidine

Cimetidine is a member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach. It has a role as an analgesic, a H2-receptor antagonist, an anti-ulcer drug, a P450 inhibitor and an adjuvant. It is a nitrile, an aliphatic sulfide, a member of guanidines and a member of imidazoles. — ChEBI

IUPAC 名称
1-cyano-2-methyl-3-[2-[(5-methyl-1H-imidazol-4-yl)methylsulfanyl]ethyl]guanidine
分子式
C10H16N6S
分子量
252.34 g/mol
精确质量
252.11571571 Da
单同位素质量
252.11571571 Da
XLogP3
0.4
拓扑极性表面积
114.0 Ų
分子复杂度
296.0
形式电荷
0
氢键供体
3
氢键受体
4
可旋转键
7
重原子
17
共价单元
1

向 PubChem 报告的名称和同义词

UlcedinEureceptorGastrometUlcimetAcinilUlcomedinaTametinCimal
另有 16 个已报告名称
AcibilinCimetagDyspametEdaleneUlcedineUlcometCimetidinaCimetumTratulUlhysSKF-92334Tagamet HbTagamet Hb 200CimetidinumMetracinUlcerfen
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
7
三维环
1
三维疏水基团
0
三维受体特征
1
三维供体特征
3
三维阴离子中心
0
三维阳离子中心
2
三维构象异构体
10
有效三维可旋转键
7.0
机器可读的结构标识符
SMILES
CC1=C(N=CN1)CSCCNC(=NC)NC#N
InChI
InChI=1S/C10H16N6S/c1-8-9(16-7-15-8)5-17-4-3-13-10(12-2)14-6-11/h7H,3-5H2,1-2H3,(H,15,16)(H2,12,13,14)
InChIKey
AQIXAKUUQRKLND-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 58-73-1 的 PubChem 二维化学结构
CAS 58-73-1PubChem CID 3100

CAS 58-73-1 的已核实化学信息

Diphenhydramine

Diphenhydramine is an ether that is the benzhydryl ether of 2-(dimethylamino)ethanol. It is a H1-receptor antagonist used as a antipruritic and antitussive drug. It has a role as a oneirogen, a sedative, a local anaesthetic, a H1-receptor antagonist, an antiparkinson drug, a muscarinic antagonist, an anti-allergic agent, an antiemetic, an antitussive, an antipruritic drug and an antidyskinesia agent. It is an ether and a tertiary amino compound. — ChEBI

IUPAC 名称
2-benzhydryloxy-N,N-dimethylethanamine
分子式
C17H21NO
分子量
255.35 g/mol
精确质量
255.162314293 Da
单同位素质量
255.162314293 Da
XLogP3
3.3
拓扑极性表面积
12.5 Ų
分子复杂度
211.0
形式电荷
0
氢键供体
0
氢键受体
2
可旋转键
6
重原子
19
共价单元
1

向 PubChem 报告的名称和同义词

BenzhydramineAlledrylProbedrylDihidralAntistominumBenzhydraminumBenzhydroaminaDiphantine
另有 16 个已报告名称
BaramineDermodrinDesentolDibondrinHistaxinBenylanDifenhidraminaDifenidraminaRestaminRigidylDiphenylhydramineDiphenhydraminumEthanamine, 2-(diphenylmethoxy)-N,N-dimethyl-O-Benzhydryldimethylaminoethanol2-(Benzhydryloxy)-N,N-dimethylethylamineFAR 90X2
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
4
三维环
2
三维疏水基团
0
三维受体特征
1
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
1
三维构象异构体
10
有效三维可旋转键
6.0
机器可读的结构标识符
SMILES
CN(C)CCOC(C1=CC=CC=C1)C2=CC=CC=C2
InChI
InChI=1S/C17H21NO/c1-18(2)13-14-19-17(15-9-5-3-6-10-15)16-11-7-4-8-12-16/h3-12,17H,13-14H2,1-2H3
InChIKey
ZZVUWRFHKOJYTH-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 68-88-2 的 PubChem 二维化学结构
CAS 68-88-2PubChem CID 3658

CAS 68-88-2 的已核实化学信息

Hydroxyzine

Hydroxyzine is a N-alkylpiperazine that is piperzine in which the nitrogens atoms are substituted by 2-(2-hydroxyethoxy)ethyl and (4-chlorophenyl)(phenyl)methyl groups respectively. It has a role as an anticoronaviral agent, an anxiolytic drug, a H1-receptor antagonist, a dermatologic drug and an antipruritic drug. It is a hydroxyether, a N-alkylpiperazine and a member of monochlorobenzenes. — ChEBI

IUPAC 名称
2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
分子式
C21H27ClN2O2
分子量
374.9 g/mol
精确质量
374.1761058 Da
单同位素质量
374.1761058 Da
XLogP3
3.7
拓扑极性表面积
35.9 Ų
分子复杂度
376.0
形式电荷
0
氢键供体
1
氢键受体
4
可旋转键
8
重原子
26
共价单元
1

向 PubChem 报告的名称和同义词

HydroxizineHydroxyzinHydroxineHydroxycineTranquizineAtaraxoidHychotineTran-Q
另有 16 个已报告名称
HydroxizinumAtarazoidNeurozinaAtazinaDeinaitFenarolPamazonePaxistilPlacidolPlaxidolAtaraAteraxneo-CalmaIdrossizinaVesparaz-WirkstoffHidroxizina
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
1
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
8
三维环
3
三维疏水基团
0
三维受体特征
2
三维供体特征
1
三维阴离子中心
0
三维阳离子中心
2
三维构象异构体
10
有效三维可旋转键
9.2
机器可读的结构标识符
SMILES
C1CN(CCN1CCOCCO)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl
InChI
InChI=1S/C21H27ClN2O2/c22-20-8-6-19(7-9-20)21(18-4-2-1-3-5-18)24-12-10-23(11-13-24)14-16-26-17-15-25/h1-9,21,25H,10-17H2
InChIKey
ZQDWXGKKHFNSQK-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 77-38-3 的 PubChem 二维化学结构
CAS 77-38-3PubChem CID 6475

CAS 77-38-3 的已核实化学信息

Chlorphenoxamine

Chlorphenoxamine is a diarylmethane. It has a role as an anticoronaviral agent. — ChEBI

IUPAC 名称
2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethylethanamine
分子式
C18H22ClNO
分子量
303.8 g/mol
精确质量
303.1389920 Da
单同位素质量
303.1389920 Da
XLogP3
4.1
拓扑极性表面积
12.5 Ų
分子复杂度
296.0
形式电荷
0
氢键供体
0
氢键受体
2
可旋转键
6
重原子
21
共价单元
1

向 PubChem 报告的名称和同义词

ContristamineClorfenoxaminaClorfenossaminaChlorphenoxaminum3UVD77BP8R2-(1-(p-Chlorophenyl)-1-phenylethoxy)-N,N-dimethylethylamine{2-[1-(4-Chlorophenyl)-1-phenylethoxy]ethyl}dimethylamine(2-(1-(4-chlorophenyl)-1-phenylethoxy)ethyl)dimethylamine
另有 16 个已报告名称
RefChem:575991D04AA34R06AA06616-456-42-(1-(4-Chlorophenyl)-1-phenylethoxy)-N,N-dimethylethanamineClorfenossamina [DCIT]2-(1-(4-Chlorophenyl)-1-phenylethoxy)-N,N-dimethylethan-1-aminep-Chlor-alpha-methyl-diphenhydramin [German]4-06-00-04717 (Beilstein Handbook Reference)p-Chlor-.alpha.-methyl-diphenhydraminAS-76607Chlorphenoxamine (INN)2-[1-(4-chlorophenyl)-1-phenyl-ethoxy]-N,N-dimethyl-ethanamineEthanamine, 2-[1-(4-chlorophenyl)-1-phenylethoxy]-N,N-dimethyl-CHLORPHENOXAMINE [INN]Ethylamine, 2-[1-(p-chlorophenyl)-1-phenylethoxy]-N,N-dimethyl-
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
1
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
4
三维环
2
三维疏水基团
0
三维受体特征
1
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
1
三维构象异构体
10
有效三维可旋转键
6.0
机器可读的结构标识符
SMILES
CC(C1=CC=CC=C1)(C2=CC=C(C=C2)Cl)OCCN(C)C
InChI
InChI=1S/C18H22ClNO/c1-18(21-14-13-20(2)3,15-7-5-4-6-8-15)16-9-11-17(19)12-10-16/h4-12H,13-14H2,1-3H3
InChIKey
KKHPNPMTPORSQE-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 82-92-8 的 PubChem 二维化学结构
CAS 82-92-8PubChem CID 6726

CAS 82-92-8 的已核实化学信息

Cyclizine

Cyclizine is an N-alkylpiperazine in which one nitrogen of the piperazine ring is substituted by a methyl group, while the other is substituted by a diphenylmethyl group. It has a role as a central nervous system depressant, a local anaesthetic, a H1-receptor antagonist, a cholinergic antagonist and an antiemetic. — ChEBI

IUPAC 名称
1-benzhydryl-4-methylpiperazine
分子式
C18H22N2
分子量
266.4 g/mol
精确质量
266.178298710 Da
单同位素质量
266.178298710 Da
XLogP3
3.6
拓扑极性表面积
6.5 Ų
分子复杂度
253.0
形式电荷
0
氢键供体
0
氢键受体
2
可旋转键
3
重原子
20
共价单元
1

向 PubChem 报告的名称和同义词

NautazineCiclizinaNeo-devomit1-(Diphenylmethyl)-4-methylpiperazineCompound 47-83CyclizinumN-Benzhydryl-N'-methylpiperazineN-Methyl-N'-benzhydrylpiperazine
另有 16 个已报告名称
(N-Benzhydryl)(N'-methyl)diethylenediamineWellcome prepn 47-831-Benzhydryl-4-methylpiperazinPiperazine, 1-(diphenylmethyl)-4-methyl-BW 47-83QRW9FCR9P2(+-)-1-diphenylmethyl-4-methylpiperazineNSC-26608CHEBI:39945-23-01-00232 (Beilstein Handbook Reference)RefChem:129230R06AE03201-445-5MarezineCyclizinum [INN-Latin]Ciclizina [INN-Spanish]
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
3
三维疏水基团
0
三维受体特征
0
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
2
三维构象异构体
6
有效三维可旋转键
4.2
机器可读的结构标识符
SMILES
CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=CC=C3
InChI
InChI=1S/C18H22N2/c1-19-12-14-20(15-13-19)18(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18H,12-15H2,1H3
InChIKey
UVKZSORBKUEBAZ-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 86-22-6 的 PubChem 二维化学结构
CAS 86-22-6PubChem CID 6834

CAS 86-22-6 的已核实化学信息

Brompheniramine

Brompheniramine is pheniramine in which the hydrogen at position 4 of the phenyl substituent is substituted by bromine. A histamine H1 receptor antagonist, brompheniramine is used (commonly as its maleate salt) for the symptomatic relief of allergic conditions, including rhinitis and conjunctivitis. It has a role as a H1-receptor antagonist and an anti-allergic agent. It is a member of pyridines and an organobromine compound. — ChEBI

IUPAC 名称
3-(4-bromophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
分子式
C16H19BrN2
分子量
319.24 g/mol
精确质量
318.07316 Da
单同位素质量
318.07316 Da
XLogP3
3.5
拓扑极性表面积
16.1 Ų
分子复杂度
249.0
形式电荷
0
氢键供体
0
氢键受体
2
可旋转键
5
重原子
19
共价单元
1

向 PubChem 报告的名称和同义词

ParabromdylamineBromfeniraminaBrompheniraminumBromfedBromfenexBrotane1-(p-Bromophenyl)-1-(2-pyridyl)-3-dimethylaminopropane3-(p-Bromophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine
另有 16 个已报告名称
2-(p-Bromo-alpha-(2-dimethylaminoethyl)benzyl)pyridineDimetapp Allergy3-(4-Bromophenyl)-N,N-dimethyl-3-(2-pyridinyl)-1-propanamineH57G17P2FNgamma-(4-Bromophenyl)-N,N-dimethyl-2-pyridinepropanamineCHEBI:31832-Pyridinepropanamine, gamma-(4-bromophenyl)-N,N-dimethyl-Pyridine, 2-(p-bromo-alpha-(2-(dimethylamino)ethyl)benzyl)-[3-(4-bromophenyl)-3-(pyridin-2-yl)propyl]dimethylaminep-Bromdylaminepara-Bromdylamine[3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl]-dimethyl-amine(3-(4-bromophenyl)-3-(pyridin-2-yl)propyl)dimethylamine(3-(4-Bromo-phenyl)-3-pyridin-2-yl-propyl)-dimethyl-aminep BromdylamineDimetane Ten
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
1
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
2
三维疏水基团
1
三维受体特征
1
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
1
三维构象异构体
10
有效三维可旋转键
5.0
机器可读的结构标识符
SMILES
CN(C)CCC(C1=CC=C(C=C1)Br)C2=CC=CC=N2
InChI
InChI=1S/C16H19BrN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
InChIKey
ZDIGNSYAACHWNL-UHFFFAOYSA-N

于 2026-09-02 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

CAS 91-81-6 的 PubChem 二维化学结构
CAS 91-81-6PubChem CID 5587

CAS 91-81-6 的已核实化学信息

Tripelennamine

Tripelennamine is an aromatic amine. — ChEBI

IUPAC 名称
N'-benzyl-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine
分子式
C16H21N3
分子量
255.36 g/mol
精确质量
255.173547683 Da
单同位素质量
255.173547683 Da
XLogP3
3.3
拓扑极性表面积
19.4 Ų
分子复杂度
236.0
形式电荷
0
氢键供体
0
氢键受体
3
可旋转键
6
重原子
19
共价单元
1

向 PubChem 报告的名称和同义词

Pyrinamine baseTripelennaminBenzoxaleResistamineCizaronTonarilPiribenzilTripelennamina
另有 16 个已报告名称
PyribenzaminTripelenaminaTripelennaminumN-benzyl-N-[2-(dimethylamino)ethyl]pyridin-2-amine1,2-Ethanediamine, N,N-dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-2-(Benzyl(2-dimethylaminoethyl)amino)pyridineN-Benzyl-N',N'-dimethyl-N-2-pyridylethylenediaminebeta-Dimethylaminoethyl-2-pyridylbenzylaminebeta-Dimethylaminoethyl-2-pyridylaminotoluene3C5ORO99TYNSC-118946N,N-Dimethyl-N'-(phenylmethyl)-N'-2-pyridinyl-1,2-ethanediamineBenzyl-(alpha-pyridyl)-dimethylaethylendiamin2-[Benzyl(2-dimethylaminoethyl)amino]pyridineN,N-Dimethyl-N'-benzyl-N'-(alpha-pyridyl)ethylenediaminePyridine, 2-(benzyl(2-(dimethylamino)ethyl)amino)-
外部数据库标识符
高级结构统计
已定义的原子立体中心
0
未定义的原子立体中心
0
已定义的键立体中心
0
未定义的键立体中心
0
三维药效团特征
5
三维环
2
三维疏水基团
0
三维受体特征
1
三维供体特征
0
三维阴离子中心
0
三维阳离子中心
2
三维构象异构体
10
有效三维可旋转键
6.0
机器可读的结构标识符
SMILES
CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2
InChI
InChI=1S/C16H21N3/c1-18(2)12-13-19(16-10-6-7-11-17-16)14-15-8-4-3-5-9-15/h3-11H,12-14H2,1-2H3
InChIKey
UFLGIAIHIAPJJC-UHFFFAOYSA-N

于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。

官方来源与出处

已登记来源
China NMPA banned raw-material catalogues (2021)
来源参考
NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 1279
来源记录 ID
chemical-1279
来源版本
NMPA Announcement No. 74 of 2021, effective 2021-05-26
来源语言
Chinese with source English/Latin identity
翻译状态
Official English translation · 英文译文
生效日期
2021-05-26
来源更新
2021-05-26
快照检查时间
2026-08-31 14:13 UTC
验证方法
pdfplumber tables; exact 1,284 + 109 row counts and contiguous source numbering
SHA-256
8848aa3e0c7ac5e74f56fc27927336c4fc2e5bc80137da087c2ca9ba2d2c075e

已登记的数据集备注

数据集覆盖范围
All 1,284 banned raw materials and 109 banned plant/animal raw materials effective from 26 May 2021
权威性说明
Binding NMPA catalogues replacing Tables 1 and 2 of the 2015 Technical Specification

本记录在市场数据集中的位置

1393
条当前 China 记录
1393
条标记为 Prohibited 的记录
1393
条来自此来源版本的记录
1249
条带有 CAS 身份的市场记录

状态分布

在 1393 条当前记录中,有 1393 条带有条件文本。条件字段为空时,按上述记录类型解释;绝不会被转换为可无限制使用的声明。

China 市场背景

Complete prohibited catalogues plus official-source workflow

覆盖版本: NMPA 2021 banned catalogues plus dynamic IECIC List I/List II system current since 2025

All 1,284 banned raw materials and 109 banned plant/animal raw materials, plus the official workflow for the dynamic existing-ingredient inventory, other technical restrictions and new ingredients.

核实清单

  1. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  2. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  3. Review technical purpose, use history and any monitoring period.
  4. Confirm Chinese labelling, safety assessment and filing/registration duties.

官方市场来源

核实工作流程与记录完整性

在将此结果用于合规决定之前

  1. 确认“抗组胺药,包括但不限于溴苯那敏及其 盐类、氯苯沙明、赛克利嗪及其盐类、 苯海拉明及其盐类、多西拉敏及其盐 类、羟嗪、曲吡那敏、西咪替丁等 — Antihistamines, including but not limited to Brompheniramine (INN) (CAS No. 86-22-6)and its salts, Chlorphenoxamine (INN) (CAS No. 77-38-3), Cyclizine (INN) (CAS No. 82-92-8) and its salts, Diphenhydramine (INN) (CAS No. 58-73-1) and its salts, Doxylamine (INN) (CAS No. 469-21-6) and its salts, Hydroxyzine (INN) (CAS No. 68-88-2), Tripelennamine (INN) (CAS No. 91-81-6), Cimetidine (INN) (CAS No. 51481-61-9)”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
  2. Search the current NMPA IECIC List I and List II by Chinese name and identity.
  3. Check prohibited/restricted and positive lists in the current Safety and Technical Standards.
  4. Review technical purpose, use history and any monitoring period.
  5. Confirm Chinese labelling, safety assessment and filing/registration duties.
  6. 记录来源版本,并在生产、备案或上市之前重新核查监管机构。

本记录中的可用字段

  • 官方物质名称可用
  • CAS可用
  • EC未提供
  • 单独的条件文本可用
  • 生效日期可用
  • 快照哈希与方法可用

本页回答的问题

This official record identifies the substance as prohibited for cosmetic use in the stated market scope. Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

A prohibition entry may contain no separate condition text because the regulatory outcome is the prohibition itself. IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.

该记录引用 NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 1279,来源版本 NMPA Announcement No. 74 of 2021, effective 2021-05-26。 打开官方来源。

不保证。CAS 有助于确定身份,但各辖区可能对同一物质作出不同分类,并可能适用不同的产品范围、限值、警示语和过渡日期。

稳定引用

抗组胺药,包括但不限于溴苯那敏及其 盐类、氯苯沙明、赛克利嗪及其盐类、 苯海拉明及其盐类、多西拉敏及其盐 类、羟嗪、曲吡那敏、西咪替丁等 — Antihistamines, including but not limited to Brompheniramine (INN) (CAS No. 86-22-6)and its salts, Chlorphenoxamine (INN) (CAS No. 77-38-3), Cyclizine (INN) (CAS No. 82-92-8) and its salts, Diphenhydramine (INN) (CAS No. 58-73-1) and its salts, Doxylamine (INN) (CAS No. 469-21-6) and its salts, Hydroxyzine (INN) (CAS No. 68-88-2), Tripelennamine (INN) (CAS No. 91-81-6), Cimetidine (INN) (CAS No. 51481-61-9). NMPA 2021 Catalogue of Raw Materials Banned for Cosmetics, entry 1279. China. Source version NMPA Announcement No. 74 of 2021, effective 2021-05-26. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/cn/records/12968/

请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。

China 的解读与局限

This official record identifies the substance as prohibited for cosmetic use in the stated market scope.

Do not rely on a formulation containing this identity until the cited source, effective date and exact substance match have been verified.

如何解读法律地位

The cited row forms part of a binding rule or legally incorporated list for this market.

本页证据

  • 记录结果:Prohibited
  • 法律地位:Binding rule
  • 来源版本:NMPA Announcement No. 74 of 2021, effective 2021-05-26
  • 生效日期:2021-05-26

它不能证明什么

IECIC listing is not blanket approval; absence may require the new cosmetic ingredient route, and restrictions are checked separately.

进一步的权威物质研究

这些来源均不能推翻上述市场决定。

Cosmetic Ingredient Review safety assessments

Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents

Independent expert review considered by FDA; not a government approval or binding market rule

在来源处研究此身份

FDA Global Substance Registration System

UNII identifiers, preferred names, substance types, codes and public substance relationships

Identity registry only; UNII availability does not imply FDA review or approval

在来源处研究此身份

ILO/WHO International Chemical Safety Cards

Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals

International occupational chemical-safety reference; not cosmetic-use approval

在来源处研究此身份

Japan NITE-CHRIP

Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information

Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules

在来源处研究此身份

NIOSH Pocket Guide to Chemical Hazards

REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals

US occupational-health guidance and limits; not a cosmetic ingredient decision

在来源处研究此身份

OECD eChemPortal

Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records

Discovery gateway; each linked authority remains responsible for its data

在来源处研究此身份

US EPA CompTox CTX APIs

导入需要 API 密钥

DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data

Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality

在来源处研究此身份